Breast Cancer Research and Treatment

, Volume 7, Issue 1, pp 47–48 | Cite as

Complete response in metastatic breast cancer

  • Charles Vogel


Public Health Breast Cancer Metastatic Breast Cancer Metastatic Breast 


  1. 1.
    Tormey DC, Kline JC, Palta M, Davis TE, Love RR, Carbone PP: Short term high density systemic therapy for metastatic breast cancer. Breast Cancer Res Treat 5: 177–188, 1985PubMedGoogle Scholar
  2. 2.
    Allegra JC, Woodcock TM, Richman SP, Kirby IB, Wittliff JL: A phase II trial of Tamoxifen, Premarin, Methotrexate and 5-Fluorouracil in metastatic breast cancer. Breast Cancer Res Treat 2: 93–100, 1982PubMedGoogle Scholar
  3. 3.
    Smalley RV, Bartolucci A, for the Southeastern Cancer Study Group: Variation in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.In: Mouridsen HT, Palshof T (eds): Breast Cancer — Experimental and Clinical Aspects. Pergamon Press, New York, 1980, pp 141–146Google Scholar
  4. 4.
    Lippman M, Sorace R, Bagley C, Lichter A, Danforth D, Wesley M, Young R: Effective systemic management of locally advanced breast cancer. Proc ASCO 1: 65, 1985Google Scholar
  5. 5.
    Burchenal JH: From wild fowl to stalking horses: alchemy in chemotherapy. Fifth Annual David A. Karnofsky Memorial Lecture. Cancer 35: 1121–1131, 1975Google Scholar

Copyright information

© Martinus Nijhoff Publishers 1986

Authors and Affiliations

  • Charles Vogel

There are no affiliations available

Personalised recommendations